{"title":"Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024 update","authors":"Jonathan A Fallowfield, Maria Jimenez Ramos","doi":"10.1080/14728214.2024.2341878","DOIUrl":null,"url":null,"abstract":"Published in Expert Opinion on Emerging Drugs (Just accepted, 2024)","PeriodicalId":12292,"journal":{"name":"Expert Opinion on Emerging Drugs","volume":"29 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Opinion on Emerging Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14728214.2024.2341878","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Published in Expert Opinion on Emerging Drugs (Just accepted, 2024)
期刊介绍:
Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.